Cipla Recalls Six Batches of Albuterol Sulfate Inhalation Aerosol


Medical Recalls

medline bed assist bar
recalled eye ointment
bluepoint laboratories potassium chloride

Medical Recall - Product Image Not Available


Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), has announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer level.

Risk Statement: There is a reasonable probability that failure to deliver the recommended dose to treat the respiratory symptoms of an acute asthma exacerbations such as wheezing coughing, shortness of breath and bronchospasms, due to device defect, may be life-threatening. There were no adverse events reported for Albuterol Sulfate Inhalation Aerosol 90 mcg related to this recall.


The company is initiating a recall in the US due to a market complaint for one single inhaler (Batch Number - IB20056), where leakage was observed through the inhaler valve. Out of an abundance of precaution, the above mentioned 6 batches manufactured using the same lot of valves are being recalled.


The product is used for the treatment and prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise induced bronchospasm. The product is packaged in 17ml plain aluminum aerosol canister integrated with dose counter coupled with plastic actuator and dust cap, each pack claims 200 metered inhalations and associated codes NDC-69097-142-60. These 6 batches were distributed Nationwide to wholesalers and retailers.


Cipla is notifying its distributors and customers by letter and is arranging for return and replacement of all recalled products.

Consumers/distributors/retailers that have product from these 6 batches which are being recalled should stop using/return to place of purchase/discard.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

"Cipla maintains stringent quality processes to assess quality defects and safety issues. Cipla conducts regular investigation and assessment by committees consisting of subject-matter experts, quality management, and medical safety experts. "

Source: FDA

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

Consumer Contact: -

Consumers with questions adverse reactions or quality problems regarding these 6 batches can contact Cipla Customer Service at 844- CIPLAUS (844-247-5287) M-F 8:30-5:00 EST, or email cipla.cs@cipla.com.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

Product Name
Batch No.
Expiry Date

Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)

IB20045

Nov.2023

Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)

IB20055

Nov.2023

Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)

IB20056

Nov.2023

Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)

IB20057

Nov.2023

Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)

IB20059

Nov.2023

Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 MI)

IB20072

Nov.2023


Report a Problem With This Product

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.

Related Posts

volara system
Baxter Issues Urgent Medical Device Recall for Volar System Single-Patient Use Circuit
Baxter Issues Urgent Medical Device Recall for Volar System Single-Patient Use Circuit
umary acido hialuronica
SoloVital Recalls Umary Acido Hialuronica, Suplemento Alimenticio 850 mg Capsules
SoloVital Recalls Umary Acido Hialuronica, Suplemento Alimenticio 850 mg Capsules
hard steel logo
Supercore Products Group, Inc. Recalls Hard Steel Capsules and Gold Hard Steel Plus Liquid
Supercore Products Group, Inc. Recalls Hard Steel Capsules and Gold Hard Steel Plus Liquid
life 2000 ventilator
Baxter Recalls Life2000 Ventilator due to Charger Issues
Baxter Recalls Life2000 Ventilator due to Charger Issues

Latest Posts

stutz packing company shelled walnuts
Stutz Packing Co. Recalls Walnut Product Because of Possible Listeria Risk
bissell steam shot handheld steam cleaner
BISSELL Recalls More Than 3 Million Steam Shot Handheld Steam Cleaners Due to Burn Hazard
manhattan toy brilliant bee rattle
Sassy Baby Recalls Manhattan Toy Brilliant Bee Rattles Due to Choking Hazard
cfmoto zforce 950 ho sport side by side rov
CFMOTO Recalls ZFORCE 950 Recreational Off-Highway Vehicles
clonazepam orally disintegrating tablets
Endo USA, Inc. Recalls Lot 550147301 of Clonazepam Orally Disintegrating Tablets

Leave a Reply

Your email address will not be published. Required fields are marked *

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.